
Blends · KLOW
KLOW (80mg)
from $89.00
Mechanism of Action
Advanced multi-peptide research blend combining BPC-157, TB-500, and GHK-CU for multi-pathway cellular studies.
Research Vectors
- Peptide blend
- Cellular research
- Multi-pathway
* Fulfillment subject to stock availability
For research purposes only.This compound is intended strictly for in-vitro laboratory research conducted by qualified professionals. It is not a drug, supplement, cosmetic, or food. It is not intended for use in or on humans or animals and has not been evaluated by the FDA for any purpose.
Recovery Blend · 80mg Total
KLOW Blend Protocol Reference Protocol
Four-compound recovery blend. Reconstituted with BAC water. Daily subcutaneous injection.
BAC Water Reconstitution
Dilution volume: Add 3 mL BAC water to the vial.
Quick-Draw Equivalents:
6 Units≈ 0.83-1.0 mg GHK-Cu
10 Units≈ 1.33-1.67 mg GHK-Cu (30 draws/vial)
12 Units= 2.0 mg GHK-Cu / 400 mcg each
Timing & Administration
☀️ Morning
Often preferred for recovery support. Fits into daily routines more easily.
🌙 Night
Some prefer nighttime as recovery processes naturally increase during sleep.
Blend Composition
GHK-Cu
50 mg
BPC-157
10 mg
TB-500
10 mg
KPV
10 mg
At 12 units (full dose), each injection delivers GHK-Cu ~2 mg · BPC-157 ~400 mcg · TB-500 ~400 mcg · KPV ~400 mcg.
Titration Schedule Guide
Full protocol dose = 12 units daily. Rounding down to 10 units gives exactly 30 injections per vial mixed with 3 mL BAC water.
| Phase | Dose | Draw Volume | Protocol Notes |
|---|---|---|---|
| Week 1 | ≈ 0.83-1.0 mg GHK-Cu | 5-6 Units | Tolerance testing and adjustment period. Approximately 167-200 mcg of each blend component. |
| Week 2 | ≈ 1.33-1.67 mg GHK-Cu | 8-10 Units | Common beginner maintenance range. 10 units = 30-injection vial split. |
| Week 3+ | = 2.0 mg GHK-Cu | 10-12 Units | Full vendor dose: 12 units = 2 mg GHK-Cu / 400 mcg each of BPC-157, TB-500, KPV. |
Cycle Protocol
Protocol: 2-3 months on followed by a 1-month break. This aligns with the standard 8-12 week range.
Observed Side Effects
Injection site irritationHeadacheFlushing / skin sensitivityNauseaFatigueAllergic-type reactions
Safety Notice: Stop and seek medical guidance if severe side effects occur.